{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:26:07Z","timestamp":1792513567632,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":582,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The spectrum of renal osteodystrophy (ROD) in peritoneal dialysis (PD) patients remains to be clarified. Ideal intact parathormone (iPTH) levels range is still not defined. The role of sclerostin, dickkopf-related protein 1, osteoprotegerin, and receptor activator for nuclear factor \u03baB ligand for the diagnosis of ROD needs to be elucidated. In this cross-sectional study, tetracycline double-labeled bone biopsy was performed in 49 patients with histomorphometric analysis according Kidney Disease Improving Global Outcomes (KDIGO) guidelines. All patients were treated with biocompatible PD solutions, with calcium concentration of 1.25\u2009mmol\/L. Adynamic bone was the most frequent diagnosed pattern (42.9%) followed by hyperparathyroid-related bone disease (28.6%). Twenty-two percent of patients had normal bone. In patients with iPTH within the KDIGO recommended range for dialysis patients, adynamic bone was found in 59% of cases. Median (range) iPTH in patients with adynamic bone was 312 (60\u2013631) pg\/mL. Median (range) levels of sclerostin varied from 1511.64 (458.84\u20136387.70)\u00a0pg\/mL in patients with hyperparathyroid bone disease to 2433.1 (1049.59\u201311354.52)\u00a0pg\/mL in patients with adynamic bone. Sclerostin\/iPTH ratio was the best marker of low turnover disease but iPTH performed best in the diagnosis of high turnover disease. Calcium mass transfer was positive in patients with low bone volume. Adynamic bone is the most frequent ROD pattern in contemporary PD. Our results suggest the need to review the iPTH target range for this population. The sclerostin\/iPTH ratio showed improved performance compared to iPTH for the diagnosis of low turnover bone. \u00a9 2022 American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4636","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T13:41:55Z","timestamp":1655300515000},"page":"1689-1699","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of Renal Osteodystrophy and Serum Bone-Related Biomarkers in a Peritoneal Dialysis Population"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-3808","authenticated-orcid":false,"given":"Luciano","family":"Pereira","sequence":"first","affiliation":[{"name":"School of Medicine University of Porto Porto Portugal"},{"name":"Department of Nephrology S\u00e3o Jo\u00e3o Hospital Center Porto Portugal"},{"name":"National Institute of Biomedical Engineering (INEB) University of Porto Porto Portugal"},{"name":"Institute of Investigation and Innovation in Health University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Magalh\u00e3es","sequence":"additional","affiliation":[{"name":"National Institute of Biomedical Engineering (INEB) University of Porto Porto Portugal"},{"name":"Institute of Investigation and Innovation in Health University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Mendon\u00e7a","sequence":"additional","affiliation":[{"name":"School of Medicine University of Porto Porto Portugal"},{"name":"Department of Nephrology S\u00e3o Jo\u00e3o Hospital Center Porto Portugal"},{"name":"National Institute of Biomedical Engineering (INEB) University of Porto Porto Portugal"},{"name":"Institute of Investigation and Innovation in Health University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Neto","sequence":"additional","affiliation":[{"name":"School of Medicine University of Porto Porto Portugal"},{"name":"Department of Nephrology S\u00e3o Jo\u00e3o Hospital Center Porto Portugal"},{"name":"National Institute of Biomedical Engineering (INEB) University of Porto Porto Portugal"},{"name":"Institute of Investigation and Innovation in Health University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janete","family":"Santos","sequence":"additional","affiliation":[{"name":"School of Medicine University of Porto Porto Portugal"},{"name":"National Institute of Biomedical Engineering (INEB) University of Porto Porto Portugal"},{"name":"Institute of Investigation and Innovation in Health University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina G","family":"Carvalho","sequence":"additional","affiliation":[{"name":"National Institute of Biomedical Engineering (INEB) University of Porto Porto Portugal"},{"name":"Institute of Investigation and Innovation in Health University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Nephrology S\u00e3o Jo\u00e3o Hospital Center Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Beco","sequence":"additional","affiliation":[{"name":"Department of Nephrology S\u00e3o Jo\u00e3o Hospital Center Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Fraz\u00e3o","sequence":"additional","affiliation":[{"name":"School of Medicine University of Porto Porto Portugal"},{"name":"Department of Nephrology S\u00e3o Jo\u00e3o Hospital Center Porto Portugal"},{"name":"National Institute of Biomedical Engineering (INEB) University of Porto Porto Portugal"},{"name":"Institute of Investigation and Innovation in Health University of Porto Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"2024012713581146500_jbmr4636-bib-0001","first-page":"376","article-title":"Low turnover bone disease is the more common form of bone disease in CAPD patients","volume":"8","author":"Rodriguez-Perez","year":"1992","journal-title":"Adv Perit Dial"},{"issue":"2","key":"2024012713581146500_jbmr4636-bib-0002","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"issue":"5","key":"2024012713581146500_jbmr4636-bib-0003","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"issue":"10","key":"2024012713581146500_jbmr4636-bib-0004","first-page":"1223","article-title":"Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation","volume":"83","author":"Changsirikulchai","year":"2000","journal-title":"J Med Assoc Thailand"},{"issue":"6","key":"2024012713581146500_jbmr4636-bib-0005","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/ndt\/gfh214","article-title":"Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study","volume":"19","author":"S\u00e1nchez","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2024012713581146500_jbmr4636-bib-0006","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","article-title":"Reversal of adynamic bone disease by lowering of dialysate calcium","volume":"70","author":"Haris","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"2024012713581146500_jbmr4636-bib-0007","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.372","article-title":"Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease","volume":"87","author":"de Oliveira","year":"2015","journal-title":"Kidney Int"},{"key":"2024012713581146500_jbmr4636-bib-0008","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"2024012713581146500_jbmr4636-bib-0009","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"2","key":"2024012713581146500_jbmr4636-bib-0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41581-018-0087-2","article-title":"Renal and extrarenal effects of fibroblast growth factor 23","volume":"15","author":"Vervloet","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"2024012713581146500_jbmr4636-bib-0011","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00223-020-00803-2","article-title":"Role of the RANK\/RANKL\/OPG and Wnt\/\u03b2-catenin systems in CKD bone and cardiovascular disorders","volume":"108","author":"Carrillo-L\u00f3pez","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"2024012713581146500_jbmr4636-bib-0012","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/ckj\/sfab081","article-title":"Sclerostin and dkk1 circulating levels associate with low bone turnover in patients with chronic kidney disease stages 3 and 4","volume":"14","author":"Neto","year":"2021","journal-title":"Clin Kidney J"},{"issue":"3","key":"2024012713581146500_jbmr4636-bib-0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11914-017-0367-y","article-title":"Renal osteodystrophy\u2014time for common nomenclature","volume":"15","author":"Ott","year":"2017","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"2024012713581146500_jbmr4636-bib-0014","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1681\/ASN.2017050584","article-title":"Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy","volume":"29","author":"Salam","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2024012713581146500_jbmr4636-bib-0015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gfh217","article-title":"A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients","volume":"19","author":"Adragao","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2024012713581146500_jbmr4636-bib-0016","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.09580911","article-title":"PTH- a particularly tricky hormone: why measure it in all patients?","volume":"8","author":"Garret","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2024012713581146500_jbmr4636-bib-0017","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/nep.12509","article-title":"Factors associated with serum soluble inhibitors of Wnt-\u03b2-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis","volume":"20","author":"Yamada","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"2024012713581146500_jbmr4636-bib-0018","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12882-019-1452-5","article-title":"Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study","volume":"20","author":"Kuo","year":"2019","journal-title":"BMC Nephrol"},{"issue":"5","key":"2024012713581146500_jbmr4636-bib-0019","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11255-018-1795-z","article-title":"Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients","volume":"50","author":"Gong","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"2024012713581146500_jbmr4636-bib-0020","doi-asserted-by":"crossref","first-page":"e0176411","DOI":"10.1371\/journal.pone.0176411","article-title":"Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD","volume":"12","author":"Behets","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"2024012713581146500_jbmr4636-bib-0021","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1159\/000501205","article-title":"Increased sclerostin, but not Dickkopf-1 protein, is associated with elevated pulse wave velocity in hemodialysis subjects","volume":"44","author":"Stavrinou","year":"2019","journal-title":"Kidney Blood Press Res"},{"issue":"22","key":"2024012713581146500_jbmr4636-bib-0022","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J Biol Chem"},{"issue":"11","key":"2024012713581146500_jbmr4636-bib-0023","doi-asserted-by":"crossref","first-page":"e98673","DOI":"10.1172\/jci.insight.98673","article-title":"Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition","volume":"3","author":"Witcher","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"2024012713581146500_jbmr4636-bib-0024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/089686089301300311","article-title":"Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25\u2009mmol\/L calcium, 0.25\u2009mmol\/L magnesium dialysis fluid","volume":"13","author":"Hutchison","year":"1993","journal-title":"Perit Dial Int"},{"issue":"4","key":"2024012713581146500_jbmr4636-bib-0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.kint.2020.07.041","article-title":"Mineral bone disease in autosomal dominant polycystic kidney disease","volume":"99","author":"Gitomer","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"2024012713581146500_jbmr4636-bib-0026","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.kint.2018.09.018","article-title":"A distinct bone phenotype in ADPKD patients with end-stage renal disease","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4636","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/9\/1689\/55456806\/jbmr4636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/9\/1689\/55456806\/jbmr4636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:45:28Z","timestamp":1710326728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/37\/9\/1689-1699\/7516625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,6,15]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4636","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4636\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4636\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4636\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4636\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4636\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4636\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4636\/v2\/review1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2022-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}